Evidence-Based Recommendations to Improve the Safe Use of Drugs in Patients with Liver Cirrhosis

INTRODUCTION: The presence of liver cirrhosis can have a major impact on pharmacodynamics and pharmacokinetics, but guidance for prescribing is lacking. OBJECTIVE: The aim of this study is to provide an overview of evidence-based recommendations developed for the safe use of drugs in liver cirrhosis...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Drug Saf
Egile Nagusiak: Weersink, Rianne A., Bouma, Margriet, Burger, David M., Drenth, Joost P. H., Harkes-Idzinga, S. Froukje, Hunfeld, Nicole G. M., Metselaar, Herold J., Monster-Simons, Margje H., Taxis, Katja, Borgsteede, Sander D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2018
Gaiak:
Original Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5966501/
https://ncbi.nlm.nih.gov/pubmed/29330714
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40264-017-0635-x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak